AI & Longevity

Session 1

Phil Newman

Editor-In-Chief, Longevity.Technology

Review of Days 1 and 2 in the context of AI.

Margaretta Colangelo

Co-founder / Managing Partner

Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics
In conversation with:

John Shepherd PhD

Co-founder, AI Precision Health Institute, University of Hawaii Cancer Center

Richard Siow PhD

Director, Longevity AI Consortium, Kings College, London

Alexander Zhavoronkov PhD

Chief Executive Officer, Insilico Medicine, Inc

5 minute coffee/bio break 🙂

Session 2

Joe Geraci

CEO and co-Founder, NetraMark Corp

Uncovering the heterogeneity & etiology of aging through modern augmented & machine intelligence

Tina Woods

CEO and Founder, Longevity International

From cells to cities

Ben Goertzel

Chief Scientist, Chairman, AI Researcher: SingularityNET, Novamente LLC, Humanity+

AI enables a holistic approach to Superlongevity

Alex Zhavoronkov

Chief Executive Officer, Insilico Medicine, Inc

Applying AI approaches to diverse aging-related problems (TBC)

5 minute coffee/bio break 🙂

Session 3

Oliver Armitage

Co-Founder & CSO, BIOS Health

BIOS is developing a full-stack neural interface platform, that uses AI to decode and encode the signals from the brain to the body, to treat chronic health conditions.

Kristen Fortney

Founder, CEO, BIOAGE

Leveraging AI, genomics, and biobanks to identify and target the molecular drivers of aging

Lou Hawthorne

CEO, NaNotics

Extending healthspan with NaNot nano-extractors

Margaretta Colangelo

Co-founder / Managing Partner

Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics

Open discussion and conclusions

Phil Newman

Editor-In-Chief, Longevity.Technology

Close and introduction to ‘Ask Me Anything’ session for VIP ticket holders

Please note: speakers, presentation titles and running order may change. This page is updated daily. Thanks.